Oral-gut axis as a novel biological mechanism linking periodontal disease and systemic diseases: A review

[1]  F. Yan,et al.  Periodontitis salivary microbiota exacerbates nonalcoholic fatty liver disease in high-fat diet-induced obese mice , 2023, iScience.

[2]  H. Tettelin,et al.  Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn’s disease , 2023, Cell reports.

[3]  Sheng-Zhong Duan,et al.  Oral Pathobionts Promote MS-like Symptoms in Mice , 2022, Journal of dental research.

[4]  A. Colombo,et al.  Oral-gut bacterial profiles discriminate between periodontal health and diseases. , 2022, Journal of periodontal research.

[5]  F. Yan,et al.  Periodontitis-related salivary microbiota aggravates Alzheimer’s disease via gut-brain axis crosstalk , 2022, Gut microbes.

[6]  Sari Kishikawa,et al.  Pathobiont-responsive Th17 cells in gut-mouth axis provoke inflammatory oral disease and are modulated by intestinal microbiome. , 2022, Cell reports.

[7]  Tamotsu Kato,et al.  Dysbiotic human oral microbiota alters systemic metabolism via modulation of gut microbiota in germ-free mice , 2022, Journal of oral microbiology.

[8]  F. Yan,et al.  Periodontitis may impair the homeostasis of systemic bone through regulation of gut microbiota in ApoE-/- mice. , 2022, Journal of clinical periodontology.

[9]  Jie Liu,et al.  Inflammatory response of gut, spleen, and liver in mice induced by orally administered Porphyromonas gingivalis , 2022, Journal of oral microbiology.

[10]  Chenyang Zhang,et al.  Correlation Analysis of Gut Microbiota and Serum Metabolome With Porphyromonas gingivalis-Induced Metabolic Disorders , 2022, Frontiers in Cellular and Infection Microbiology.

[11]  G. Hajishengallis.  Interconnection of periodontal disease and comorbidities: Evidence, mechanisms, and implications. , 2022, Periodontology 2000.

[12]  C. Genco,et al.  Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection , 2022, Frontiers in Oral Health.

[13]  Weibin Sun,et al.  Experimental Periodontitis Deteriorated Atherosclerosis Associated With Trimethylamine N-Oxide Metabolism in Mice , 2022, Frontiers in Cellular and Infection Microbiology.

[14]  T. Tomonaga,et al.  Intestinal microbe-dependent ω3 lipid metabolite αKetoA prevents inflammatory diseases in mice and cynomolgus macaques , 2022, Mucosal immunology.

[15]  Yijun Sun,et al.  Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4+ T cells. , 2021, Molecular oral microbiology.

[16]  C. Westwater,et al.  Commensal gut bacterium critically regulates alveolar bone homeostasis , 2021, Laboratory Investigation.

[17]  Fengyin Liang,et al.  Porphyromonas gingivalis-Induced Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction , 2021, Frontiers in Cellular and Infection Microbiology.

[18]  Y. Huang,et al.  Periodontitis Salivary Microbiota Worsens Colitis , 2021, Journal of dental research.

[19]  Keyang Chen,et al.  Ligature induced periodontitis in rats causes gut dysbiosis leading to hepatic injury through SCD1/AMPK signalling pathway. , 2021, Life sciences.

[20]  W. Giannobile,et al.  A potential pathogenic association between periodontal disease and Crohn’s disease , 2021, JCI insight.

[21]  R. F. de Souza,et al.  Oral Dysbiosis in Severe Forms of Periodontitis Is Associated With Gut Dysbiosis and Correlated With Salivary Inflammatory Mediators: A Preliminary Study , 2021, Frontiers in Oral Health.

[22]  Shujiro Okuda,et al.  Oral Pathobiont-Induced Changes in Gut Microbiota Aggravate the Pathology of Nonalcoholic Fatty Liver Disease in Mice , 2021, Frontiers in Immunology.

[23]  C. Staley,et al.  No evidence for colonization of oral bacteria in the distal gut in healthy adults , 2021, Proceedings of the National Academy of Sciences.

[24]  T. Bamba,et al.  Porphyromonas gingivalis induces entero-hepatic metabolic derangements with alteration of gut microbiota in a type 2 diabetes mouse model , 2021, Scientific Reports.

[25]  Scott C. Thomas,et al.  The Gut Microbiome, Metformin, and Aging. , 2021, Annual review of pharmacology and toxicology.

[26]  Xijie Yu,et al.  Gut microbiota and bone metabolism , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Shujiro Okuda,et al.  Obesity-Related Gut Microbiota Aggravates Alveolar Bone Destruction in Experimental Periodontitis through Elevation of Uric Acid , 2021, mBio.

[28]  F. Scannapieco,et al.  Dysbiosis revisited. Understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: a critical assessment. , 2021, Journal of periodontology.

[29]  F. Yan,et al.  Gut Microbiota May Mediate the Influence of Periodontitis on Prediabetes , 2021, Journal of dental research.

[30]  Rongjun Guo,et al.  Differences in the oral and intestinal microbiotas in pregnant women varying in periodontitis and gestational diabetes mellitus conditions , 2021, Journal of oral microbiology.

[31]  E. Elinav,et al.  Maturation of the neonatal oral mucosa involves unique epithelium-microbiota interactions. , 2020, Cell host & microbe.

[32]  Wei Zhou,et al.  Activated STAT3 signaling pathway by ligature-induced periodontitis could contribute to neuroinflammation and cognitive impairment in rats , 2020, Journal of neuroinflammation.

[33]  Haifeng Lu,et al.  Periodontitis in elderly patients with type 2 diabetes mellitus: impact on gut microbiota and systemic inflammation , 2020, Aging.

[34]  Z. Pei,et al.  Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice , 2020, Journal of neuroinflammation.

[35]  Hirokazu Takahashi,et al.  Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Xuedong Zhou,et al.  Probiotics ameliorate alveolar bone loss by regulating gut microbiota , 2020, Cell proliferation.

[37]  T. Kawai,et al.  Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model , 2020, Arthritis Research & Therapy.

[38]  R. Casarin,et al.  Oral and Fecal Microbiome in Molar-Incisor Pattern Periodontitis , 2020, Frontiers in Cellular and Infection Microbiology.

[39]  W. Giannobile,et al.  The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis , 2020, Cell.

[40]  M. Nedergaard,et al.  Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus. , 2020, Trends in molecular medicine.

[41]  Hamid Y. Dar,et al.  Microbiota dependent production of butyrate is required for the bone anabolic activity of PTH. , 2020, The Journal of clinical investigation.

[42]  A. Horigome,et al.  Relationship between oral and gut microbiota in elderly people , 2019, Immunity, inflammation and disease.

[43]  Xuedong Zhou,et al.  Oral bacteria colonize and compete with gut microbiota in gnotobiotic mice , 2019, International Journal of Oral Science.

[44]  X. Li,et al.  Gut microbiota composition and bone mineral loss—epidemiologic evidence from individuals in Wuhan, China , 2019, Osteoporosis International.

[45]  Luis Pedro Coelho,et al.  Extensive transmission of microbes along the gastrointestinal tract , 2018, bioRxiv.

[46]  Y. Date,et al.  Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome , 2018, mSphere.

[47]  T. Ushiki,et al.  A bacterial metabolite ameliorates periodontal pathogen-induced gingival epithelial barrier disruption via GPR40 signaling , 2018, Scientific Reports.

[48]  M. McGuire,et al.  Periodontal manifestations of systemic diseases and developmental and acquired conditions: Consensus report of workgroup 3 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of periodontology.

[49]  Y. Izumi,et al.  Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism , 2017, Scientific Reports.

[50]  J. Segre,et al.  Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.

[51]  F. Pirih,et al.  Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis , 2017, PloS one.

[52]  Tamotsu Kato,et al.  Aggravation of collagen-induced arthritis by orally administered Porphyromonas gingivalis through modulation of the gut microbiota and gut immune system , 2017, Scientific Reports.

[53]  H. Steinkamp,et al.  Commensal Gut Microbiota Immunomodulatory Actions in Bone Marrow and Liver have Catabolic Effects on Skeletal Homeostasis in Health , 2017, Scientific Reports.

[54]  Wenjie Gao,et al.  Diversity analysis of gut microbiota in osteoporosis and osteopenia patients , 2017, PeerJ.

[55]  R. Ingalls,et al.  Distinct roles for dietary lipids and Porphyromonas gingivalis infection on atherosclerosis progression and the gut microbiota. , 2017, Anaerobe.

[56]  J. Chandan,et al.  The impact of inflammatory bowel disease on oral health , 2017, BDJ.

[57]  K. Takeuchi,et al.  Relative abundance of total subgingival plaque-specific bacteria in salivary microbiota reflects the overall periodontal condition in patients with periodontitis , 2017, PloS one.

[58]  F. Bäckhed,et al.  Signals from the gut microbiota to distant organs in physiology and disease , 2016, Nature Medicine.

[59]  R. Oppermann,et al.  Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. , 2016, Journal of clinical periodontology.

[60]  K. Yamazaki.  New paradigm in the relationship between periodontal disease and systemic diseases , 2016 .

[61]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[62]  K. Honda,et al.  The microbiota in adaptive immune homeostasis and disease , 2016, Nature.

[63]  Kassem M. Makki,et al.  Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition , 2016, Science.

[64]  J. Bilezikian,et al.  Parathyroid hormone: anabolic and catabolic actions on the skeleton. , 2015, Current opinion in pharmacology.

[65]  M. Kamal,et al.  Correlation of Toll-like receptor 4, interleukin-18, transaminases, and uric acid in patients with chronic periodontitis and healthy adults. , 2015, Journal of periodontology.

[66]  Beiwen Zheng,et al.  Alterations of the human gut microbiome in liver cirrhosis , 2014, Nature.

[67]  D. Motooka,et al.  Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota , 2014, Scientific Reports.

[68]  David Artis,et al.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis , 2014, Nature Reviews Immunology.

[69]  I. Olsen,et al.  Bacteria and bacterial DNA in atherosclerotic plaque and aneurysmal wall biopsies from patients with and without periodontitis , 2014, Journal of oral microbiology.

[70]  S. Abramson,et al.  Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity , 2014, Current opinion in rheumatology.

[71]  L. Pereira,et al.  Probiotic therapy reduces periodontal tissue destruction and improves the intestinal morphology in rats with ligature-induced periodontitis. , 2013, Journal of periodontology.

[72]  Thomas J. Wang,et al.  A diabetes-predictive amino acid score and future cardiovascular disease. , 2013, European heart journal.

[73]  G. Seymour,et al.  Periodontal disease and systemic illness: will the evidence ever be enough? , 2013, Periodontology 2000.

[74]  Richard A. Moore,et al.  Co-occurrence of anaerobic bacteria in colorectal carcinomas , 2013, Microbiome.

[75]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[76]  R. Zubarev,et al.  Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis , 2013, Annals of the rheumatic diseases.

[77]  J. Goedert,et al.  Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study , 2012, Journal of Translational Medicine.

[78]  Levi Waldron,et al.  Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples , 2012, Genome Biology.

[79]  J. Nicholson,et al.  Host-Gut Microbiota Metabolic Interactions , 2012, Science.

[80]  Panos N Papapanou,et al.  Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. , 2012, Circulation.

[81]  V. Tremaroli,et al.  The gut microbiota regulates bone mass in mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[82]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[83]  M. Serdar,et al.  Salivary infectious agents and periodontal disease status. , 2011, Journal of periodontal research.

[84]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[85]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[86]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[87]  P. Miossec,et al.  IL-17 as a future therapeutic target for rheumatoid arthritis , 2009, Nature Reviews Rheumatology.

[88]  L. Kesavalu,et al.  Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease. , 2007, Oral microbiology and immunology.

[89]  J. Ferrières,et al.  Metabolic Endotoxemia Initiates Obesity and Insulin Resistance , 2007, Diabetes.

[90]  S. Humphrey,et al.  A review of saliva: normal composition, flow, and function. , 2001, The Journal of prosthetic dentistry.

[91]  S. Alaluusua,et al.  Salivary Levels of Suspected Periodontal Pathogens in Relation to Periodontal Status and Treatment , 1995, Journal of dental research.

[92]  Hiroshi Kataoka,et al.  Uric acid as a danger signal in gout and its comorbidities , 2013, Nature Reviews Rheumatology.

[93]  P. Savelkoul,et al.  Comparison of subgingival bacterial sampling with oral lavage for detection and quantification of periodontal pathogens by real-time polymerase chain reaction. , 2007, Journal of periodontology.